nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Associations of total and aerobic steps with the prevalence and incidence of frailty in older adults with hypertension
|
Lefferts, Elizabeth C. |
|
|
67 |
C |
p. 18-25 |
artikel |
2 |
Cardiopulmonary exercise testing during the COVID-19 pandemic
|
Mihalick, Virginia L. |
|
|
67 |
C |
p. 35-39 |
artikel |
3 |
Cardiovascular Statistics 2021
|
Lavie, Carl J. |
|
|
67 |
C |
p. 114-115 |
artikel |
4 |
Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study
|
Krittanawong, Chayakrit |
|
|
67 |
C |
p. 108-110 |
artikel |
5 |
Cover 2 (Masthead)
|
|
|
|
67 |
C |
p. IFC |
artikel |
6 |
Covid-19 vaccine- induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma
|
Gupta, Aashish |
|
|
67 |
C |
p. 105-107 |
artikel |
7 |
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes
|
Palazzuoli, Alberto |
|
|
67 |
C |
p. 89-97 |
artikel |
8 |
Editorial Board
|
|
|
|
67 |
C |
p. A5 |
artikel |
9 |
Effects of statins on myocarditis: A review of underlying molecular mechanisms
|
Parsamanesh, Negin |
|
|
67 |
C |
p. 53-64 |
artikel |
10 |
Exercise blood pressure, cardiorespiratory fitness and mortality risk
|
Kokkinos, Peter |
|
|
67 |
C |
p. 11-17 |
artikel |
11 |
How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors
|
Cybulska, Barbara |
|
|
67 |
C |
p. 65-74 |
artikel |
12 |
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)
|
Ruscica, Massimiliano |
|
|
67 |
C |
p. 40-52 |
artikel |
13 |
List of recent issues
|
|
|
|
67 |
C |
p. A4 |
artikel |
14 |
Mitral valve diseases: Pathophysiology and interventions
|
Harky, Amer |
|
|
67 |
C |
p. 98-104 |
artikel |
15 |
Prioritizing movement to address the frailty phenotype in heart failure
|
Laddu, Deepika R. |
|
|
67 |
C |
p. 26-32 |
artikel |
16 |
Prognostic value of troponin I in atrial fibrillation
|
Quesada, Aurelio |
|
|
67 |
C |
p. 80-88 |
artikel |
17 |
Special Assorted Topics 2021
|
Lavie, Carl J. |
|
|
67 |
C |
p. 1 |
artikel |
18 |
Table of contents
|
|
|
|
67 |
C |
p. A1-A3 |
artikel |
19 |
The need for exercise sciences and an integrated response to COVID-19: A position statement from the international HL-PIVOT network
|
Faghy, Mark A. |
|
|
67 |
C |
p. 2-10 |
artikel |
20 |
The obesity wars and the education of a researcher: A personal account
|
Flegal, Katherine M. |
|
|
67 |
C |
p. 75-79 |
artikel |
21 |
Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States
|
Narasimhan, Bharat |
|
|
67 |
C |
p. 111-113 |
artikel |
22 |
Vaccine and physical activity in the era of COVID-19 pandemic
|
Ghram, Amine |
|
|
67 |
C |
p. 33-34 |
artikel |